Related Experiment Video

Updated: Jun 13, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Achieving treatment goals in low-risk, asymptomatic patients

Keith C Ferdinand1

  • 1Division of Cardiology, Emory University. kferdinand@abcardio.org

The Journal of the American Osteopathic Association
|May 11, 2010
PubMed

Insights

Traditional coronary heart disease (CHD) risk assessments often miss individual factors like race and lipids. Personalized strategies are needed to accurately assess and manage cardiovascular event risk.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Diagnostics

Background:

  • Current coronary heart disease (CHD) risk assessments frequently overlook crucial individual variables, including race and lipid profiles.
  • Discrepancies exist among established treatment guidelines for metabolic syndrome, leading to clinical confusion.
  • While advanced cardiac biomarkers and imaging aid in detecting subclinical atherosclerosis, their cost-effectiveness for routine screening remains unproven.

Observation:

  • Physicians face challenges in tailoring diagnostic and management strategies for CHD.
  • Individual patient factors significantly influence the risk of CHD and cardiovascular events.
  • The utility of novel diagnostic tools is limited by cost-effectiveness concerns.

Findings:

  • Standard risk factor assessments are insufficient for comprehensive CHD risk evaluation.
  • Personalized medicine approaches are essential for accurate cardiovascular risk stratification.
  • Integrating diverse patient data is key to effective CHD management.

Implications:

  • There is a need for refined CHD risk assessment tools that incorporate individual patient characteristics.
  • Clinical practice guidelines require harmonization to reduce confusion in metabolic syndrome management.
  • Further research is necessary to establish the cost-effectiveness of advanced cardiac diagnostic methods for widespread adoption.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...